First Time Use of SD-809 in Huntington Disease
Clinical trial NCT01795859 · COMPLETED
Trial details
- NCT number
- NCT01795859
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-05
- Primary completion
- 2014-12-05
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.